News

FDA to speed up AI rollout to accelerate drug reviews
The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) ...
OpenAI CEO, other US tech leaders testify to Congress on AI competition with China
OpenAI CEO Sam Altman and executives from Microsoft and chipmaker Advanced Micro Devices testified on Capitol Hill about the biggest opportunities, risks and needs facing an industry which lawmakers ...
OpenAI CEO Sam Altman: ChatGPT will ‘probably not’ replace Google as top search engine
A U.S. Senate subcommittee hearing on American AI competitiveness this morning stretched for more than three hours — long ...
Ted Cruz calls for 'light touch' on AI in hearing with OpenAI, Microsoft
U.S. Sen Ted Cruz called Thursday for the federal government to take a "light touch" in regulating tech companies as they ...
OpenAI wants to cut Microsoft's revenue share by half by 2030 — following Sam Altman's botched for-profit restructure plan
OpenAI reportedly plans to slash Microsoft's revenue share after the ChatGPT maker's CEO announced that the AI firm jumped ...
Microsoft adopts Google’s standard for linking up AI agents
Microsoft says that it's embracing Google's recently launched open protocol, Agent2Agent, for allowing AI 'agents' to ...
OpenAI expects to cut share of revenue it pays Microsoft by 2030
OpenAI sees itself paying a lower share of revenue to its investor and close partner Microsoft by 2030 than it currently does ...
OpenAI plays into Elon Musk's hands, ditching for-profit plan — but Sam Altman doesn't have Microsoft's blessing yet
While OpenAI jumped ship from its initial plan to evolve into a for-profit entity, billionaire Elon Musk isn't satisfied yet.